NTRB Stock Analysis: Buy, Sell, or Hold?
NTRB - Nutriband Inc. Common Stock
$3.60
0.01 (0.28%)
▲
5d:
-4.0%
30d:
-11.98%
90d:
-12.41%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 29, 2026
10d
Get Alerted When NTRB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called NTRB this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: NTRB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: NTRB shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$5.69
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$3.53
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.8x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: NTRB is currently trading at $3.60, which is considered oversold relative to its 30-day fair value range of $3.69 to $4.10. From a valuation perspective, the stock is trading at a discount (Forward PE: 2.5) compared to its historical average (2.8). Remarkably, the market is currently pricing in an annual earnings decline of 4.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, NTRB is in a downtrend. The price is currently testing key support at $3.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NTRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.00 (+316.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, NTRB is in a downtrend. The price is currently testing key support at $3.50. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: NTRB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.00 (+316.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.69 -
$4.10
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 316.7% below Wall St target ($15.00)
Trading Range Analysis
30-Day Trading Range
$3.69 -
$4.10
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.50
Resistance Level
$4.18
Current Trend
Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
2.48
Wall Street Target
$15.00
(+316.7%)
Revenue Growth (YoY)
-46.4%
Valuation Discount vs History
-4.5% cheaper
PE vs Historical
2.5 vs 2.8
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.5%
(market-implied from PE analysis)
1-Year Target
$3.44
(-5%)
2-Year Target
$3.28
(-9%)
3-Year Target
$3.14
(-13%)
3-Yr Target (if PE normalizes)
(PE: 2→3)
$3.54
(-2%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 2.5 to 2.8
Stabilization Target:
$4.06
(+12.8%)
PE Expansion Potential:
+12.8%
Share & Embed Analysis
Last updated: May 18, 2026 4:15 AM ET
Data refreshes hourly during market hours. Next update: 5:15 AM
Data refreshes hourly during market hours. Next update: 5:15 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is NTRB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 63 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 50 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$35 | 55 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$293 | 60 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$126 | 48 HOLD |
